Angela L. Wirick - Mar 1, 2024 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Role: Chief Financial Officer
Signature: /s/ Angela L. Wirick
Stock symbol: ATRC
Transactions as of: Mar 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/5/2024, 04:46 PM
Previous filing: Aug 8, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATRC	Common Stock	Award	$0	+31K	+35.81%	$0.00	118K	Mar 1, 2024	Direct	F1
transaction	ATRC	Common Stock	Award	$0	+16.5K	+14%	$0.00	134K	Mar 1, 2024	Direct	F2
transaction	ATRC	Common Stock	Options Exercise	$84.8K	+5K	+3.73%	$16.95	139K	Mar 1, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATRC	Non-qualified Stock Option (right to buy)	Options Exercise	-$84.8K	-5K	-100%	$16.95	0	Mar 1, 2024	Non-qualified Stock Option (right to buy)	5K	$16.95	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.
F2	The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.
F3	These options were granted on July 28, 2014. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.